Clinical Trial Update: A Registry to Evaluate the Performance of the BDX-XL2 Test

View source ↗

Summary

This document reports a completed clinical trial registry evaluating the performance of the BDX-XL2 diagnostic test.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solitary Pulmonary Nodule

Drugs mentioned

• BDX-XL2 test

Snippet

Sponsor: Biodesix, Inc. | Conditions: Nodule Solitary Pulmonary, NSCLC | Status: COMPLETED